FDA Announces Joint Meeting of Advisory Committees to Discuss Transmissible Spongiform Encephalopathies and Vaccines

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of the Transmissible Spongiform Encephalopathies Advisory Committee and the Vaccines and Related Biological Products Advisory Committee to discuss recent developments in the field of transmissible spongiform encephalopathies and vaccines, with the meeting to take place on an upcoming date.